Stanford Biotechnology Symposium

Stanford Biotechnology Symposium
Tuesday, October 27, 2020 - 2:00pm
Abstract / Description: 

Stanford Biotechnology Symposium 2020

You are cordially invited to attend a special 2-hour symposium, hosted by the Stanford-NIH Biotechnology Predoctoral Training Grant program.
The goal of this annual symposium is to highlight exciting cutting-edge research at Stanford, and to also facilitate broader connections and community building around biotechnology at Stanford and the Bay Area. We hope you will join us!

When: Tuesday, October 27, 2020

Where: Virtual (via Zoom, registration required)

Time: 2 pm to 4 pm (PST)



Daphne Koller is CEO and Founder of insitro, a company applying machine learning to drug development. Daphne was a Computer Science Professor at Stanford, co-founder and co-CEO of Coursera, and Chief Computing Officer of Calico. Daphne was one of TIME Magazine's 100 most influential people and is a MacArthur Fellow, a member of the National Academy of Engineering, and a Fellow of the American Academy of Arts and Sciences and the International Society of Computational Biology.

Peter S. Kim is the Virginia & D.K. Ludwig Professor of Biochemistry at Stanford University School of Medicine and an Institute Scholar of Stanford ChEM-H. He is also the Lead Investigator of the Infectious Disease Initiative at the Chan Zuckerberg Biohub. He was President of Merck Research Laboratories from 2003–2013 and oversaw development of more than 20 new medicines and vaccines, including JANUVIA, GARDASIL, ISENTRESS, ZOSTAVAX, and KEYTRUDA. Earlier, he was Professor of Biology at MIT, Member of the Whitehead Institute and an HHMI Investigator. He is known for discovering a salient component of how proteins cause viral membranes to fuse with cells and has pioneered efforts to create an AIDS vaccine based on inhibiting the HIV-1 membrane-fusion process. He is a member of the National Academy of Sciences, the National Academy of Medicine and the National Academy of Engineering.